The pilot is a significant departure from the current model, which gives hospitals upfront discounts for some drugs.

Viatris (Nasdaq: VTRS), a global healthcare company, today announced that five abstracts from its Phase 3 program evaluating novel fast-acting formulation of meloxicam (MR-107A-02) in ...

Aventis Energy (CSE:AVE; OTC: VBAMF) announced the launch of its KorrAI technology program in partnership with KorrAI ...

Aventis Energy (“Aventis” or the “Company”) (CSE:AVE | FRA:C0O0 | OTC: VBAMF) is pleased to announce that it has commenced its KorrAI Technology Program (the “Program”) with KorrAI Technologies Inc. ( ...

Professor David Meyer (CivMin) and CivMin PhD student Omar Abdelazeem synthesized best practices to create the SWMMIN model ...

SBOMs are, in essence, the ingredient labels of the software world. Raidman helped shape the field by contributing to U.S.